Estroven
Perimenopause Relief + Weight
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
16
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
3 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Black Cohosh Root Extract Black CohoshUNII · K73E24S6X9 | 40 mg | — |
| Soy Isoflavones isoflavone (unspecified) | 56 mg | — |
| CQR-300 Cissus quadrangularis stem and leaf extract Cissus quadrangularis | 300 mg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
16
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · Microcrystalline Cellulose · Dicalcium Phosphate · Croscarmellose Sodium · Stearic Acid · Silicon Dioxide · natural Vanilla powder · Magnesium Stearate